| Prev Close | 107.74 |
| Day Low/High | 108.07 / 109.21 |
| 52 Wk Low/High | 62.55 / 113.41 |
AbbVie, Inc. (ABBV)
108.41
NYSE
| Exchange | NYSE |
| Shares Outstanding | 1765.88B |
| Market Cap | 190.26B |
| P/E Ratio | 90.13 |
| Div & Yield | N.A. (N.A) |
Jim Cramer: Know This Before You Join the Trading Revolution
Put down the slingshot and study these seven tenets.
Shock & Awe Markets, Bank Stocks, Apple's Debt Move, Trading Amazon, ServiceNow
Right off the top, the bubble has burst for the 'short squeeze' names such as GameStop and AMC Entertainment.
Jim Cramer: You Just Won Powerball, Now What?
Remember, you only need to get rich once.
8 Quality Dividend Stocks for Durable Growth and Income
Four experts highlight their favorite dividend stocks for 2021.
Jim Cramer: 10 Big Dividend Stocks I Like Now
I think investors deserve much better than to say that there's no opportunity for income in this market.
AbbVie Is a Stock to Position for 2021
Let's review the charts and indicators.
Jim Cramer: 10 Investment Themes I Like in 2021
I am talking about themes that can stand the test not of today, or tomorrow, but for all of 2021 and beyond.
I Dislike Picking a Top Pick for the Year, but Here Is Mine for 2021
It's a stock that underperformed the last two years but would likely excel in a year of renewed growth in economic activity.
How I'm Playing Astra-Zeneca on Vaccine and Acquisition News
I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.
Jim Cramer: The 10 Tipping Points That Took Us to Dow 30,000
All in all stick with the tipping pointers, they are the drivers of this and the next leg higher.
November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks
Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.
My Election Day Wish, Tech Sector Performance, Trading Amazon and 6 Other Stocks
Here's to the removal of uncertainty -- and thousands of campaign signs on thousands of lawns in my neighborhood.
Pausing for Thought, Parsing GDP, Laying Out a Game Plan, Sizing Up Big Tech
Plus, we check out up the bevy of reasons for this week's negative market behavior.
Immatics Is a Bit Boy Who Cried Wolf
This is the type of chart that will grab the attention of momentum traders.
This Dividend Stock's Got the Right Medicine for Investors
AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector.
Weakening Dollar, Fiscal Relief Gridlock, Walmart+, Trading Albemarle
Also, interpreting Tuesday's market, Covid-19 vaccine update, and manufacturing growth.
A Healthy Dose of Vaccine and Pharmaceutical Plays
6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.
Stay Patient With AbbVie
I would continue to hold ABBV, and here's why.
2 Biotech Stocks to Buy on Solid Q2 Results
Covid-19 has had a big impact on this sector, but these names have strong catalysts going into the next quarter.
Let's Not Overlook AbbVie's Q2 Beat
There is no thought of selling here and now, even with politicized pressure on the industry.
Grotesque GDP, So Much for Rotation, Amazon Goes Wild: Market Recon
Plus, it could be quite a while before the labor market can absorb all those people who are out of jobs.
7 Drug Stocks With the Right Medicine for Investors
These pharmaceutical favorites continue to make progress on a number of fronts including a Covid-19 vaccine.
SPACs Aren't Just for Trading: 2 Attractive Buy and Hold Opportunities
I like putting some of my money with incredibly successful folks who are well-connected and have a history of success.
AbbVie Is Concocting a Formula for a Breakout
Here's an updated strategy for ABBV, which could see new highs soon.
The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance
I have always liked the aggressive management.
The Charts of AbbVie Can Reach New Heights
A lifting on the moratorium on elective procedures could be a big win for ABBV.
Jim Cramer: This Opening Is the Beginning of the End of the Healthcare Recession
What's really driving the market, what's making the Nasdaq roar? Tech and science, that's what.
Markets Test Support Levels, Amazon Earnings, Calibrating for Covid-19
The market sold off on Thursday after close as big hitters, including Amazon, reported earnings.
